Can paclitaxel be given in dextrose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Paclitaxel Administration in Dextrose

Yes, paclitaxel can be safely administered in 5% dextrose solution. This is an established and widely accepted practice supported by multiple guidelines and stability studies.

Approved Diluents

Paclitaxel is compatible with two standard diluents 1, 2:

  • 5% dextrose in water (D5W)
  • 0.9% sodium chloride (normal saline)

Both diluents are equally acceptable for paclitaxel administration, with no clinical preference for one over the other 3.

Concentration Requirements

When preparing paclitaxel infusions, the following concentration parameters must be followed 2, 3:

  • Final concentration range: 0.3-1.2 mg/mL
  • The drug must be diluted 5-20 times from its original formulation before administration 4
  • Concentrations outside this range risk precipitation or inadequate dilution

Stability in Dextrose

Paclitaxel demonstrates excellent stability when diluted in 5% dextrose 2, 3:

  • At room temperature (25°C): Stable for at least 27 hours in clinical practice, with some studies showing 3-7 days depending on concentration and container type 1, 3
  • Refrigerated (2-8°C): Stable for 13-20 days at 0.3 mg/mL concentration, depending on container type 3
  • Lower concentrations (0.3 mg/mL) are more stable than higher concentrations (1.2 mg/mL) 3

Container and Administration Requirements

Critical equipment specifications must be followed when using dextrose as the diluent 5:

  • Use only glass bottles, polyolefin bags, or polypropylene bags - never use PVC containers 2, 5
  • Polypropylene-lined infusion tubing is required 5
  • 0.22 micron in-line filter must be used during administration 5

These requirements exist because the Cremophor EL vehicle (polyoxyethylated castor oil) used to solubilize paclitaxel can leach plasticizers from PVC materials 6, 4.

Clinical Considerations

The choice between dextrose and saline does not impact hypersensitivity reaction risk 6:

  • Hypersensitivity reactions occur in 4-10% of patients and are attributed to the Cremophor EL excipient, not the active drug or diluent 6
  • Premedication with corticosteroids and H1-antihistamines is mandatory regardless of diluent choice, reducing reaction rates from 30% to 3% 6
  • Reactions typically occur during the first or second administration 6

Common Pitfall to Avoid

Do not use PVC containers or tubing with paclitaxel in any diluent, including dextrose. The Cremophor EL vehicle will extract diethylhexylphthalate plasticizers from PVC materials, causing both equipment damage and potential patient toxicity 4. Always verify that polyolefin or polypropylene materials are being used 2, 3.

References

Research

Physical and chemical stability of paclitaxel infusions in different container types.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2006

Research

Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges.

Critical reviews in therapeutic drug carrier systems, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.